Meat/Poultry

RSS

In May 2024, USDA-FSIS published a final determination setting levels at which Salmonella would be considered an adulterant in not-ready-to-eat (NRTE), breaded and stuffed chicken products, which also established a verification sampling program and a requirement for establishments to reassess their HACCP plans. FSIS has delayed the date for its sampling program and the HACCP reviews from May to November, 2025.

Food Standards Australia New Zealand (FSANZ) has approved its first cell-based food product—quail meat—bringing the product closer to market and establishing a regulatory framework in the national Food Standards Code.

The European Food Safety Authority (EFSA) has alerted the public that pathogens resistant to last-resort carbapenem antibiotics are increasingly being found in European food animals and food products.

After an investigation by the UK Food Standards Agency, four men and one business have been convicted for diverting meat and animal byproducts that were deemed unsafe for human consumption back into the human food market.

A study from Public Health Agency of Canada researchers raised concerns about the persistence of Salmonella and Campylobacter in broiler chickens that are resistant to important Category I antimicrobials.

Consumer Reports recently released a report revealing the “most contaminated” poultry plants in the U.S., based on an analysis of USDA-FSIS Salmonella testing data.

Precision Downtime, a new software solution from Ancera, helps poultry integrators reduce downtime during flock transitions by leveraging real-time, farm-specific data based on microbial risk assessments.

A joint report from the European Food Safety Authority (EFSA) and the European Center for Disease Control and Prevention (ECDC) shows that resistance to key antibiotics among important foodborne pathogens is persistently high in both humans and animals.

Eagle Product Inspection recently unveiled its redesigned Pipeline X-Ray System for pumped products, offering improved machine construction and built-in inspection technologies.

USDA has announced the availability of financial investments to combat the ongoing highly pathogenic avian influenza H5N1 outbreak, including $500 million for farm biosecurity and $100 million for the development of chicken vaccines and other therapeutics.